Advertisement

Search Results for "Ppi High Dose For Gerd"

23:21 EDT 23rd May 2013 | BioPortfolio

Original Source: High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease

It has been reported that Baclofen is an appropriate tool in the therapeutic management of Gastroesophageal Reflux Disease. To objectify gastroesophageal reflux combined pH-metry/impedance monitoring was applied to patients with persistent reflux-associated symptoms despite PPI-therapy (40mg esomeprazole for 2 weeks). After provement of pathological findings in the test PPI-dosage was escalated to double standard-dosage for another for weeks. In case of persistent symptoms anot...

Matching Channels

Gastroesophageal Reflux Disease GERD

GERD is a condition which develops when the reflux of stomach contents causes troublesome symptoms (ie at least two heartburns per week) and/or complications. Predisposing factors include dysfunctio...

Prostate Cancer

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or...

Thimerosal Preservative

Thimerosal is a mercury-based preservative that has been used for decades in the United States in multi-dose vials (vials containing more than one dose) of some vaccines to prevent the growth of ger...

High administrative costs

High anion gap acidosis

Matching News

Health Tip: Don't Let GERD Interrupt Your Sleep

-- Gastroesophageal reflux disease (GERD) is a gastrointestinal condition that often triggers uncomfortable nighttime heartburn that affects sleep. The National Sleep Foundation lists these suggestion...

GERD Label May Cause Parents To Over-Medicate Their Baby

Doctors often label common symptoms in babies, such as spitting up and crying, as gastroesophageal reflux disease (GERD), however, frequent use of this diagnosis can result in overuse of medication. W...

GERD: GERD symptoms can resolve in overweight and obese people who lose weight

Prevalence, Incidence and Spontaneous Loss of GERD Symptoms

How common is it for the symptoms of GERD to change over time? This new study explains. Gut

History of GERD in the Community and Its Effect on Survival

What are some of the most common symptoms of GERD, and how do their severity affect survival in patients? Alimentary Pharmacology & Therapeutics

Diagnosing GERD: GerdQ-based Algorithm vs Endoscopy

Diagnosing GERD can be a challenge. This new study looks at the effectiveness of a patient questionnaire in helping clinicians make a proper diagnosis. Alimentary Pharmacology & Therapeutics

Eisai announces FDA acceptance of AcipHex NDA for priority review

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review Eisai's New Drug Application (NDA) for AcipHex Delayed-Release Sprinkle Capsules 5mg and 10...

GERD Questionnaire in Real-world Practice

Could a questionnaire given to patients help clinicians with a GERD diagnosis and treatment plan? Journal of Gastroenterology and Hepatology

Matching PubMed Articles

Development of a refractory gastro-oesophageal reflux score using an administrative claims database.

Background  Approximately one-third of gastro-oesophageal reflux disease (GERD) patients demonstrate refractory symptoms following treatment with proton pump inhibitor (PPI) therapy. Aim  To devel...

Impedance pH Confirms the Relationship Between GERD and BMI.

BACKGROUND: During the last 20 years the prevalence of both gastroesophageal reflux disease (GERD) and obesity has been increasing in the United States. The pathophysiology of GERD is multifactorial...

Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan.

BACKGROUND: To seek a promising therapeutic regimen for proton pump inhibitor (PPI)-refractory patients with gastroesophageal reflux disease (GERD) after the standard PPI treatme...

Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research G

BACKGROUNDS: Some non-erosive reflux disease (NERD) and reflux esophagitis (RE) patients are unresponsive to a proton pump inhibitor (PPI) at standard dose. We investigated the predictive marker of th...

Proton Pump Inhibitor Prescriptions and Subsequent Use in US Veterans Diagnosed with Gastroesophageal Reflux Disease.

BACKGROUND: Empiric proton pump inhibitor use is common for gastroesophageal reflux disease (GERD), but initial proton pump inhibitor (PPI) prescription patterns in Veterans are unknown. OBJECTIVE: Th...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement